Use of Wearables to Detect Infections in Kidney Transplant Recipients
NCT ID: NCT06364618
Last Updated: 2024-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2024-09-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
1. What are the biometric data pattern changes in impending infections?
2. What accuracy the machine learning algorithm can achieve?
Participants will be given/use their own wearable device that will record biometric data. Any infection event will be recorded and an algorithm will be trained to recognize changes in biometric data preceding symptomatic infection.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Increasing Activity Post-Kidney Transplant With SystemCHANGE
NCT03191630
Multimorbidity and Cardiovascular Risk Factors After Renal Transplant
NCT07205692
Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation
NCT03227965
Preventing Outcomes Through Effective Cardiovascular Risk Reduction After Transplant II
NCT02003469
LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration
NCT05570929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18 years or more
* kidney allograft function (eGFR based on CKD-EPI more than 15ml/min/1.73m2)
Exclusion Criteria
* terminal failure of another organ (heart, liver, lung)
* diabetes mellitus type 1
* pregnant or breastfeeding woman
* refusal to give informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute for Clinical and Experimental Medicine
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Ondřej Viklický, M.D., Ph.D.
Head of Transplantation Center, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Clinical and Experimental Medicine
Prague, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
G-24-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.